Author:
Kresken M., ,Hafner D.,Wiedemann B.,Mittermayer H.,Verbist L.,Bergogne-Bérézin E.,Giamarellou Helena,Esposito S.,van Klingeren B.,Kayser F. H.,Reeves D. S.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference13 articles.
1. Ronald, A. R., Turck, M., Petersdorf, R. G. A critical evaluation of nalidixic acid in urinary-tract infections. N. Engl. J. Med. 297 (1966) 1081–1089.
2. Wolfson, J. S. Hooper, D. C. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activityin vitro. Antimicrob. Agents Chemother. 28 (1985) 581–586.
3. Hooper, D. C., Wolfson, J. S. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob. Agents Chemother. 28 (1985) 716–721.
4. Kresken, M., Wiedemann, B. Development of resistance in the past decade in Central Europe. J. Antimicrob. Chemother. 18 (Suppl. C) (1986) 235–242.
5. Kresken, M., Wiedemann, B. Die Epidemiologie der Resistenz bei Bakterien und ihre Bedeutung für die Wirksamkeit von Chemotherapeutika. FAC Fortschr. Antimicrob. Antineoplast. Chemother. 6-6 (1987) 869–1063.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献